British Journal of Clinical Pharmacology

Papers
(The H4-Index of British Journal of Clinical Pharmacology is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Issue Highlights81
64
Issue Information63
56
Pharmacokinetics of the inactive favipiravir metabolite, favipiravir hydroxide (M1), as a proxy for establishing metabolic activity in patients receiving intravenous favipiravir for treatment of SARS‐54
Opioid‐related deaths and their counterpart by occurrence era, age group and coimplicated drugs: Scotland vs. England and Wales54
Chemometrics as a valuable tool for evaluating interactions between antiretroviral drugs and food51
Analysis of factors influencing the relationship between voriconazole plasma concentrations and adverse effects in a paediatric population49
Letter to the editor concerning the article: ‘The impacts of undetected nonadherence in phase II, III and post‐marketing clinical trials: An overview’47
Model‐based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non‐complicated methicillin‐resistant staphylococcus aureus infection46
Pharmacokinetics, safety and efficacy study in pregnancy and existing cumulative data/evidence to support clinical use and labelling of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in pre45
A scoping review of thresholds for responder and time‐to‐event analysis of patient‐reported outcomes in breast cancer trials42
Prospective evaluation of pregnancy outcomes after gestational exposure to prazosin42
Design of a pharmacokinetic/pharmacodynamic model for administration of low dose peripheral norepinephrine during general anaesthesia42
Letter to the editor of the Brit J Clin Pharmacol on Hartjes et al. 2025 https://doi.org/10.1002/bcp.7017640
Drug reaction with eosinophilia and systemic symptoms induced by paclitaxel, a rare combination36
Incidence, clinical classification and risk factors of cyclosporin A‐induced liver injury in allogeneic haematopoietic stem cell transplant recipients36
Case report: Dolutegravir dosing post‐Roux‐en‐Y gastric bypass surgery36
Impact of codeine rescheduling on prescribing of codeine and other opioids: Interrupted time series analyses using Australian general practice data36
Serum uric acid lowering mediated by glucagon‐like peptide‐1 receptor agonists: Emerging considerations35
Modelling the progression of illicit substance use patterns from real‐world evidence35
Epidural methadone and morphine pharmacokinetics and clinical effects in healthy volunteers: A randomized, crossover‐design trial34
Effects of intraoperative low‐dose esketamine on postoperative pain after vestibular schwannoma resection: A prospective randomized, double‐blind, placebo‐controlled study34
Neck‐vein thrombosis during spaceflight33
Quantification of sertraline maternal/fetal ratio and amniotic fluid concentration using a pregnancy physiologically based pharmacokinetic model31
Effect of oral clonidine on pain reduction in patients with opioid use disorder in the emergency department: A randomized clinical trial30
Selected Abstracts from Pharmacology 202430
Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry29
Pharmacogenetic CYP2B6 variants affect steroid hormone metabolism in human breast cancer cells29
Does coprescribing nonsteroidal anti‐inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism?29
0.99381899833679